Accelerating Plasmid Construct Development with Smart Bioreactors
About this webinar
Unlock the potential of plasmid fermentation processes with data-driven experimentation using cloud-connected, small-scale bioreactor technology.
This webinar highlights how real-time insights from bioreactor-based plasmid construct development can accelerate research and development. By enabling seamless data transfer between remote sites, teams were able to monitor experiments in real time, make immediate process adjustments and plan subsequent runs more efficiently.
This approach not only saved time and reduced costs but also improved data quality and decision-making. As a result, R&D teams were better equipped to evaluate which plasmid constructs to advance or discontinue, streamlining development pathways.
Register for this webinar to learn how cloud-connected bioreactors can accelerate the screening and selection of optimal plasmid constructs by enabling real-time data access, streamlined collaboration and smarter workflows.
Who should attend
- Small-mid-large biotech/pharma
- Emerging biotechs
- Process Development Scientists
- Process Development Engineers
- Directors/VPs of Process Development
- Chief Scientific Officers (CSO)
What you will learn
- Understand how leveraging cloud-integrated 250 mL bioreactors enables rapid and remote evaluation of plasmid fermentation processes, providing crucial early-stage data accessible anywhere, anytime
- Gain insights from expert case studies demonstrating how cloud-connected bioreactor systems facilitate seamless data transfer and enhanced collaboration across different teams and locations for diverse biopharmaceutical processes
- Learn how the integration of cloud platforms allows real-time process monitoring, which enables faster, more informed decision-making in bioprocess development
Featured Speakers
Jean-Marc Guedon, PhD
Jean-Marc has been working on mammalian process development throughout his career. He has developed, evaluated and optimized mammalian processes for viral vectors and proteins. Jean-Marc holds an MSc in Molecular Microbiology and Immunology from Johns Hopkins and a PhD in Molecular Virology and Microbiology from the University of Pittsburgh.
Mariana Bego, PhD
Mariana has focused her career on various aspects of manufacturability assessments, molecular biology and viral immunology. She currently leads the AAV plasmid process development team at Alexion, AstraZeneca Rare Disease. She holds a degree in Biotechnology from Argentina, an MS in Pharmacy from the University of Florida, and a PhD in Molecular and Cell Biology from the University of Nevada, Reno.
Partner for this event
Culture Biosciences
Culture Biosciences is dedicated to innovation in upstream bioprocess development. Culture’s goal is to build new tools and services that improve the performance, time-to-develop, and cost-efficiency of therapeutic manufacturing processes. The company’s proprietary, fully integrated platform combines bioreactors, cloud-based software, and services to offer client companies around the world access to predictable, and scalable bioprocess development. Culture Biosciences was founded in 2016 and is based in South San Francisco, CA. For more information visit: www.culturebiosciences.com
Related webinars
More from Culture Biosciences.
AI in Bioprocessing Today — Accelerate. Predict. Deliver.
Smart Solutions for Bioprocessing: Accelerating Results Using Cloud-Connected Hardware
Cloud-Connected Bioreactors: Optimizing Synthetic Biology Scale-Up
Future of Bioprocessing: Bioprocessing 4.0 and Cloud Computing
Upstream Bioprocessing: DoE Optimization for CHO Cell Cultures